TNF and tuberculosis: Inhibition of TNFα and TNF-regulated chemokine networks is the presumed biological basis for the 4 to 5 fold higher incidence of tuberculosis observed after initiation of anti-TNF therapy with infliximab, in patients latently infected with M. tuberculosis[1–3].